المؤلفون: Urosevic J; Cancer Science Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; CIBERONC, Spain., Blasco MT; Cancer Science Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; CIBERONC, Spain., Llorente A; Cancer Science Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Bellmunt A; Cancer Science Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Berenguer-Llergo A; Biostatistics and Bioinformatics Unit, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Guiu M; Cancer Science Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Cañellas A; Cancer Science Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; CIBERONC, Spain., Fernandez E; Cancer Science Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Burkov I; Cancer Science Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Clapés M; Cancer Science Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Cartanà M; Cancer Science Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Figueras-Puig C; Cancer Science Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Batlle E; Cancer Science Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; CIBERONC, Spain.; ICREA, Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain., Nebreda AR; Cancer Science Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; ICREA, Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain., Gomis RR; Cancer Science Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain. roger.gomis@irbbarcelona.org.; CIBERONC, Spain.; ICREA, Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain.; School of Medicine, Universitat de Barcelona, Barcelona, Spain.

المصدر: Cancer research [Cancer Res] 2020 Nov 01; Vol. 80 (21), pp. 4668-4680. Date of Electronic Publication: 2020 Aug 19.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Angiopoietin-2/*biosynthesis , Colonic Neoplasms/*pathology , MAP Kinase Signaling System/*physiology , Neoplasm Invasiveness/*pathology , Receptors, CXCR4/*biosynthesis, Animals ; Colonic Neoplasms/genetics ; Gene Expression Regulation, Neoplastic/physiology ; Heterografts ; Humans ; Liver Neoplasms/secondary ; Mice ; Neoplasm Invasiveness/genetics ; Up-Regulation